BSX
Boston ScientificBNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Procedure volumes recover quickly, new product launches gain commercial traction, and reimbursement remains stable—driving margin expansion and a rerating toward the bull target (155) within 12 months.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta 0.0.
What can break
Large legal judgments or elevated litigation reserve
Momentum
4
Value
63
Sentiment
86
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $115.00 · Bull $155.00 · Bear $85.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-23 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $71.36
Why
Momentum4 · Δ7d -0.8
Value63 · Δ7d +0.6
Sentiment86 · Δ7d 0.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
4
26% active weight
Current posture
7d trendFlat
Δ7d
-0.8
Δ21d
+0.1
Value
63
39% active weight
Current posture
7d trendFlat
Δ7d
+0.6
Δ21d
+1.0
Sentiment
86
34% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade B. Momentum 4.4 / Value 63.2 / Sentiment 86.0
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$65.44B
Beta
0.67
Shares Out
1.49B
P/E (TTM)
51.1
P/S (TTM)
7.31
P/FCF (TTM)
37.02
Rev YoY
+11.6%
EPS YoY
+98.7%
Gross Margin
+65.4%
Op Margin
+17.9%
Net Debt
$9.93B
Current Ratio
1.90
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology